<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN"
        "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?>
    <front>
        <journal-meta>
            <journal-id journal-id-type="nlm-ta">Front Chem</journal-id>
            <journal-id journal-id-type="iso-abbrev">Front Chem</journal-id>
            <journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
            <journal-title-group>
                <journal-title>Frontiers in Chemistry</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2296-2646</issn>
            <publisher>
                <publisher-name>Frontiers Media S.A.</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="pmcid">4365737</article-id>
            <article-id pub-id-type="doi">10.3389/fchem.2015.00017</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Chemistry</subject>
                    <subj-group>
                        <subject>Mini Review</subject>
                    </subj-group>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>The elusive nature and diagnostics of misfolded A&#x003b2; oligomers</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Cerasoli</surname>
                        <given-names>Eleonora</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                    <uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/205620"/>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ryadnov</surname>
                        <given-names>Maxim G.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                    <uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/96728"/>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Austen</surname>
                        <given-names>Brian M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                    <xref ref-type="author-notes" rid="fn001">
                        <sup>*</sup>
                    </xref>
                    <uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/199718"/>
                </contrib>
            </contrib-group>
            <aff id="aff1">
                <sup>1</sup>
                <institution>Biotechnology Department, National Physical Laboratory, SW1 5EY</institution>
                <country>Teddington, UK</country>
            </aff>
            <aff id="aff2">
                <sup>2</sup>
                <institution>Basic Medical Sciences, St. George's University of London, EH106KL</institution>
                <country>London, UK</country>
            </aff>
            <author-notes>
                <fn fn-type="edited-by">
                    <p>Edited by: Graham Lorimer Simpson, GlaxoSmithKline, UK</p>
                </fn>
                <fn fn-type="edited-by">
                    <p>Reviewed by: Luis &#x000c1;lvarez De Cienfuegos Rodr&#x000ed;guez, University of Granada, Spain;
                        Juan Jose Diaz-Mochon, University of Granada, Spain; Richard B. Parsons, King's College London,
                        UK
                    </p>
                </fn>
                <corresp id="fn001">*Correspondence: Brian M. Austen, St. George's University of London, Cranmer
                    Terrace, London SW17 0RE, UK
                    <email xlink:type="simple">sghk200@sgul.ac.uk</email>
                </corresp>
                <fn fn-type="other" id="fn002">
                    <p>This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal
                        Frontiers in Chemistry
                    </p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>19</day>
                <month>3</month>
                <year>2015</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2015</year>
            </pub-date>
            <volume>3</volume>
            <elocation-id>17</elocation-id>
            <history>
                <date date-type="received">
                    <day>15</day>
                    <month>12</month>
                    <year>2014</year>
                </date>
                <date date-type="accepted">
                    <day>24</day>
                    <month>2</month>
                    <year>2015</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright &#x000a9; 2015 Cerasoli, Ryadnov and Austen.</copyright-statement>
                <copyright-year>2015</copyright-year>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open-access article distributed under the terms of the Creative Commons
                        Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted,
                        provided the original author(s) or licensor are credited and that the original publication in
                        this journal is cited, in accordance with accepted academic practice. No use, distribution or
                        reproduction is permitted which does not comply with these terms.
                    </license-p>
                </license>
            </permissions>
            <abstract>
                <p>Amyloid-beta (A&#x003b2;) peptide oligomers are believed to be the causative agents of Alzheimer's
                    disease (AD). Though post-mortem examination shows that insoluble fibrils are deposited in the
                    brains of AD patients in the form of intracellular (tangles) and extracellular (plaques) deposits,
                    it has been observed that cognitive impairment is linked to synaptic dysfunction in the stages of
                    the illness well before the appearance of these mature deposits. Increasing evidence suggests that
                    the most toxic forms of A&#x003b2; are soluble low-oligomer ligands whose amounts better correlate
                    with the extent of cognitive loss in patients than the amounts of fibrillar insoluble forms.
                    Therefore, these ligands hold the key to a better understanding of AD prompting the search for
                    clearer correlations between their structure and toxicity. The importance of such correlations and
                    their diagnostic value for the early diagnosis of AD is discussed here with a particular emphasis on
                    the transient nature and structural plasticity of misfolded A&#x003b2; oligomers.
                </p>
            </abstract>
            <kwd-group>
                <kwd>A&#x003b2; oligomers</kwd>
                <kwd>neurodegeneration</kwd>
                <kwd>protein misfolding</kwd>
                <kwd>fibrillogenesis</kwd>
                <kwd>Alzheimer's disease</kwd>
            </kwd-group>
            <counts>
                <fig-count count="2"/>
                <table-count count="0"/>
                <equation-count count="0"/>
                <ref-count count="71"/>
                <page-count count="6"/>
                <word-count count="4976"/>
            </counts>
        </article-meta>
    </front>
    <body>
        <sec>
            <title>Protein conformational disorders</title>
            <p>Cerebral proteopathies including Alzheimer's, Parkinson's, and Huntington's diseases result from
                progressive amyloidogenesis for which protein misfolding is the cause (Eisenberg and Jucker,<xref
                        rid="B12" ref-type="bibr">2012</xref>). The complexity of these diseases is the main reason
                behind the persistent lack of efficient therapeutic approaches. Traditional drug development relies on
                finding a therapeutic target which for most diseases can be traced down to an individual molecule,
                mutation or infection. In contrast, proteopathies are process disorders which develop over many years
                through a chain of conformational changes starting with an abnormally folded protein or/as in prion
                diseases, as a result of permissive templating of an endogenous protein by an exogenous amyloidogenic
                form. Therefore, proteopathies are often referred to as protein conformational disorders with a
                particular emphasis on a specific causative agent. This mini-review focuses on one of such agents&#x02014;amyloid-beta
                or A&#x003b2;&#x02014;and discusses the elusive nature of its development into cytotoxic oligomers (Meli
                et al.,<xref rid="B43" ref-type="bibr">2014</xref>).
            </p>
            <p>A&#x003b2; stands for a proteolytic product of a transmembrane amyloid precursor protein (APP). This is a
                40&#x02013;42 residue peptide which constitutes a primary structural component of insoluble fibrils
                accumulating in microscopic deposits, senile plaques, that are found in the post-mortem brains of
                Alzheimer's disease (AD) patients (Glenner and Wong,<xref rid="B17" ref-type="bibr">1984</xref>; Masters
                et al.,<xref rid="B41" ref-type="bibr">1985</xref>). Early studies showed that in such plaques A&#x003b2;
                existed in a stable multimeric form and some credence was given to the role of A&#x003b2; in the disease
                by the demonstration that aggregated forms of A&#x003b2; were toxic to neuronal cells
                <italic>in vitro</italic>
                and
                <italic>in vivo</italic>
                (Walsh and Selkoe,<xref rid="B65" ref-type="bibr">2007</xref>), whereas monomeric, soluble forms were
                innocuous. However, no correlation was found between the number of amyloid plaques in brain and the
                extent of cognition loss in examined brains of AD patients. Instead, better correlations were apparent
                between (i) the total amount of soluble and insoluble &#x003b2;-amyloid in brain and cognitive decline
                (McLean et al.,<xref rid="B42" ref-type="bibr">1999</xref>) and (ii) the amounts of A&#x003b2; oligomers
                and the extent of cognitive loss in patients as opposed to the number of fibrils (Glabe,<xref rid="B16"
                                                                                                              ref-type="bibr">
                    2008</xref>). These findings are in a striking agreement with that fibrils are less toxic to neurons
                than soluble oligomers (Sakono and Zako,<xref rid="B55" ref-type="bibr">2010</xref>) and that lowering
                the cytotoxicity of &#x003b2;-amyloid does not necessarily reduce fiber formation (Zerovnik et al.,<xref
                        rid="B70" ref-type="bibr">2011</xref>; Jiang et al.,<xref rid="B26" ref-type="bibr">2013</xref>
                ). Therefore, A&#x003b2; fibrils can be viewed as repositories of soluble intermediates that are in
                equilibrium with insoluble forms (Bieschke et al.,<xref rid="B4" ref-type="bibr">2012</xref>) (Figure
                <xref ref-type="fig" rid="F1">1</xref>).
            </p>
            <fig id="F1" position="float">
                <label>Figure 1</label>
                <caption>
                    <p><bold>Schematic representations of (A) spontaneous A&#x003b2; aggregation from &#x003b2;-sheet&#x02013;nucleating
                        monomers (lag) phase to &#x003b2;-sheet-rich oligomers, protofibrils and fibrils (PDB entries
                        1BEG, 2LFM, 2GSP, and 2OTK)</bold>. Fibril model is reproduced under the terms of the creative
                        Commons Attribution non-commercial license from Marshall (<xref rid="B39" ref-type="bibr">
                            2009</xref>).
                        <bold>(B)</bold>
                        Two elementary units, &#x003b2;-hairpin and &#x003b2;-arch, leading to different assembly
                        pathways (PDB entries 2OTK and 2LNQ rendered by Swiss PDB Viewer).
                    </p>
                </caption>
                <graphic xlink:href="fchem-03-00017-g0001"/>
            </fig>
            <p>Outstanding questions relate to the precise relationships between the primary and secondary structure of
                A&#x003b2; and those tertiary interactions that underpin different polymorphic forms, transient or
                equilibrated, but which remain elusive to most experimental conditions that fail to adequately replicate
                A&#x003b2; aggregation pathways (Bitan et al.,<xref rid="B5" ref-type="bibr">2005</xref>; Philo,<xref
                        rid="B51" ref-type="bibr">2006</xref>). Yet again, it is becoming apparent that it is the
                conformational plasticity of A&#x003b2; which is responsible for the observed polymorphism and toxicity
                (Hubin et al.,<xref rid="B23" ref-type="bibr">2014</xref>). Along the same lines, it is reasonable to
                consider a sequence of nucleating processes each of which may potentially lead to different cytotoxicity
                (Necula et al.,<xref rid="B47" ref-type="bibr">2007</xref>; Miller et al.,<xref rid="B44"
                                                                                                ref-type="bibr">
                    2010</xref>). Such a notion prompts an important conclusion that key factors for the cytotoxic
                effects of &#x003b2;-amyloid may be confined to interactions between soluble oligomers and cellular
                membranes (Broersen et al.,<xref rid="B6" ref-type="bibr">2010</xref>), (Broersen et al.,<xref rid="B6"
                                                                                                               ref-type="bibr">
                    2010</xref>; Stefani,<xref rid="B61" ref-type="bibr">2012</xref>) favoring stronger binders (Miller
                et al.,<xref rid="B44" ref-type="bibr">2010</xref>).
            </p>
        </sec>
        <sec>
            <title>A&#x003b2; oligomerisation: conformation, size and elementary units</title>
            <p>In fibrils A&#x003b2; is arranged into a parallel, in-register cross-beta architecture in which
                individual &#x003b2;-sheets run perpendicular to the fibril axis. A &#x003b2;-turn-&#x003b2; arc, which
                in contrast to a &#x003b2;-hairpin is side-chain-bonded, is reported as an elementary unit for both
                fibrils and nucleators (Kajava et al.,<xref rid="B28" ref-type="bibr">2010</xref>) but remains
                unrecognized as a dominant conformation for oligomers. Largely this is due to the more pronounced
                conformational plasticity of A&#x003b2; in low oligomeric structures which are prone to specific changes
                in response to environmental factors (Miller et al.,<xref rid="B44" ref-type="bibr">2010</xref>).
            </p>
            <p>Encouragingly, such a permissive conformational background as well as polymorphic plasticity allow for
                the development of conformation-dependent oligomer-specific antibodies. For example, OC polyclonal
                antibodies recognize fibrils or fibrillar oligomers but not pre-fibrillar oligomers which though have
                broadly the same sizes are immunologically different and are recognized by A11 antibodies (Kayed et al.,
                <xref rid="B30" ref-type="bibr">2003</xref>,<xref rid="B29" ref-type="bibr">2007</xref>). Fibrils and
                pre-fibrillar oligomers therefore have different conformation-dependent epitopes which suggests that
                oligomer conformations are likely to be main determinants of cytotoxicity (Ladiwala et al.,<xref
                        rid="B33" ref-type="bibr">2012</xref>). Although pre-fibrillar oligomers can vary in size and
                morphology (Benilova et al.,<xref rid="B71" ref-type="bibr">2012</xref>) their variety is dependent on
                experimental conditions used (Lee et al.,<xref rid="B35" ref-type="bibr">2007</xref>; Gillam and
                MacPhee,<xref rid="B15" ref-type="bibr">2013</xref>). The size alone thus cannot serve as a reliable
                indicator of oligomer conformation or toxicity. Similarly, the morphology of soluble aggregates, which
                tends to be dominated by spheroidal forms (Lambert et al.,<xref rid="B34" ref-type="bibr">1998</xref>),
                seem to bear little relevance to size-dependent toxicity. Low oligomers, often termed amyloid-derived
                diffusible ligands (ADDLs), are believed to range in diameter from 1 to 15 nm (Hoshi et al.,<xref
                        rid="B22" ref-type="bibr">2003</xref>), with similar morphologies expressed at the micrometer
                scale (Westlind-Danielsson and Arnerup,<xref rid="B66" ref-type="bibr">2001</xref>). &#x003b2;-hairpins
                stabilized into U-shape conformations are maintained in these structures. Deviations in in-register
                &#x003b2;-sheet arrangements occur with increasing size when the assembly is forced to adopt a twist
                which destabilizes further fibril-like growth thus limiting the assembly to lower oligomers. In
                contrast, twist pairs as small as A&#x003b2; pentamers can be stabilized through a hydrophobic interface
                to seed conformational templates for fibrillogenesis (Kahler et al.,<xref rid="B27" ref-type="bibr">
                    2013</xref>).
            </p>
            <p>However, any assignment of a specific conformation is hampered by the heterogeneity and instability of
                lower oligomers, and consequently questions the existence of a specific toxic oligomer (Hubin et al.,
                <xref rid="B23" ref-type="bibr">2014</xref>). Analysing the dynamics of the conformational space
                available to A&#x003b2; may provide better insights. For example, proteolytic cleavage of SDS-stable
                globule-like aggregates helped to reveal a C-terminal part of A&#x003b2; sequence buried in the
                hydrophobic core suggesting conformational adaptability of a solvent-exposed N-terminal fragment
                (Barghorn et al.,<xref rid="B3" ref-type="bibr">2005</xref>). Proposed as intermediates toward fibril
                formation (Chimon and Ishii,<xref rid="B8" ref-type="bibr">2005</xref>) these structures were found to
                be toxic pre-fibrillar oligomers (A11-positive) suggesting that the supramolecular packing of a similar
                elementary &#x003b2;-sheet unit is different from that in fibrils (Chimon et al.,<xref rid="B9"
                                                                                                       ref-type="bibr">
                    2007</xref>). In pre-fibrillar oligomers the unit was found to be an anti-parallel &#x003b2;-sheet
                followed by an in-register, parallel intermolecular sheet (Olejniczak et al.,<xref rid="B48"
                                                                                                   ref-type="bibr">
                    2008</xref>; Yu et al.,<xref rid="B69" ref-type="bibr">2009</xref>). With the dimer covalently
                locked through an introduced disulphide bond, the oligomers could still be recognized by the same
                antibody suggesting constraint-independent binding (Yu et al.,<xref rid="B69" ref-type="bibr">
                    2009</xref>). More recent evidence broadens potential pathways to toxic oligomers with mechanisms
                involving out-of-register &#x003b2;-sheets (Liu et al.,<xref rid="B38" ref-type="bibr">2012</xref>) and
                staggered anti-parallel arrangements (Tay et al.,<xref rid="B62" ref-type="bibr">2013</xref>).
            </p>
            <p>In this light, revealing an elementary monomeric conformation appears to be timely and appealing. In an
                exemplary attempt, an A&#x003b2; monomer covalently locked into a stabilized &#x003b2;-hairpin was shown
                to associate into oligomeric and pre-fibrillar structures but not mature fibrils, while, remarkably,
                exhibiting cytotoxicity and antibody recognition typical of native oligomers (Sandberg et al.,<xref
                        rid="B56" ref-type="bibr">2010</xref>; Dubnovitsky et al.,<xref rid="B11" ref-type="bibr">
                    2013</xref>). These results confirm that A&#x003b2; peptide (primary structure) folded into a
                hairpin (secondary structure) constitutes the elementary monomeric motif supporting the formation of
                oligomers.
            </p>
            <p>However, links between the elementary units and their tertiary arrangements in oligomers are far less
                clear. Some evidence points in favor of oligomeric intermediates having specific structural topologies,
                e.g., assembled &#x003b2;&#x02013;barrels, which are A11-positive. Given that the binding of A11 is
                sequence-independent and that it recognizes other non-amyloid oligomers including &#x003b1;-haemolysin
                and heat shock proteins (Yoshiike et al.,<xref rid="B68" ref-type="bibr">2008</xref>), these proposed
                topologies are likely to be off-pathway intermediates. For the same reason, the structures could
                represent oligomeric forms adopted by other amyloid-forming peptides, and can be used as &#x003b2;-sheet
                amyloid mimetics.
            </p>
            <p>Uncertainties in providing explicit relationships between secondary and tertiary structures in transient
                oligomers encourage alternative representations of monomeric units. One of such alternatives is an
                atypical secondary structure motif&#x02014;an &#x003b1;-sheet. Similar to &#x003b2;-sheets this
                structure forms pleated structures which however differ by that all peptide-bond carbonyls lie in the
                same direction on one side of the pleat while all amino groups mirror the arrangement on the opposite
                side of the pleat. This enables opposite charges on the opposite edges of one pleat, also referred to as
                a polar pleated sheet, and more pronounced sheet flattening (Pauling and Corey,<xref rid="B50"
                                                                                                     ref-type="bibr">
                    1951</xref>; Armen et al.,<xref rid="B1" ref-type="bibr">2004</xref>). Peptides designed to adopt
                this secondary structure were able to bind toxic oligomers of two unrelated amyloid proteins, A&#x003b2;
                (1-42) and transthyretin (TTR) (Armen et al.,<xref rid="B1" ref-type="bibr">2004</xref>; Hopping et al.,
                <xref rid="B21" ref-type="bibr">2014</xref>). The structure is also considered as promising for
                addressing the main paradox of structure-activity relationships in amyloidogenesis by delineating the
                dependence of the process on peptide sequences from that it is mainly driven by backbone stabilization
                factors.
            </p>
            <p>Yet, this and any other alternative structures can only provide indirect evidence which would require
                validation for native amyloidogenic sequences.
            </p>
        </sec>
        <sec>
            <title>A&#x003b2; oligomers: toxicity and synaptic degeneration</title>
            <p>AD is the most common form of dementia which affects episodic memory. Plasticity of the synapse would
                appear to be intimately involved (Martin et al.,<xref rid="B40" ref-type="bibr">2000</xref>), whereas
                the structure of the synaptic network changes in response to external or internal stimuli enabling at a
                later date the repeated access to those stimuli. Thus, the most damaged facet of memory in AD is the
                loss of semantic memory, the store of factual and conceptual knowledge that is not linked to a specific
                memory.
            </p>
            <p>Changing the strength of synaptic connections between neurons is widely thought to be the mechanism by
                which memory traces are encoded and stored in the brain. This hypothesis states that activity dependant
                synaptic plasticity is induced at appropriate synapses during memory formation and is necessary and
                sufficient for the information storage underlying memory. An exemplary insight into how A&#x003b2;
                production and aggregation may give rise to memory loss
                <italic>in vivo</italic>
                (Kayed and Lasagna-Reeves,<xref rid="B31" ref-type="bibr">2013</xref>) can be demonstrated by a recent
                finding (Russell et al.,<xref rid="B54" ref-type="bibr">2012</xref>).
            </p>
            <p>Specifically, A&#x003b2; oligomers blocked long-term potentiation (LTP) in the hippocampal slices of
                fetal rats. LTP is an experimental paradigm of synaptic plasticity, which is characterized by an
                increasing response with repeated stimulation over time. A&#x003b2; oligomers at nanomolar levels
                derived by incubation of synthetic A&#x003b2;, or isolation from cellular supernatants, blocked
                maintenance but not initiation of LTP. Blockage was alleviated by the additional presence of protecting
                antibody or the application of scrambled A&#x003b2; (Walsh et al.,<xref rid="B64" ref-type="bibr">
                    2002</xref>). There is plenty of direct experimental evidence to support the notion of toxic
                oligomers (Walsh et al.,<xref rid="B64" ref-type="bibr">2002</xref>; Kayed et al.,<xref rid="B30"
                                                                                                        ref-type="bibr">
                    2003</xref>,<xref rid="B29" ref-type="bibr">2007</xref>; Haass and Selkoe,<xref rid="B18"
                                                                                                    ref-type="bibr">
                    2007</xref>; Tomic et al.,<xref rid="B63" ref-type="bibr">2009</xref>; Mucke and Selkoe,<xref
                        rid="B46" ref-type="bibr">2012</xref>; Lesne et al.,<xref rid="B36" ref-type="bibr">2013</xref>
                ), also suggesting that the activity of causing dementia may occur across a broad oligomer range. For
                example, A&#x003b2; dodecamers were identified in human brain extracts and found to bind cultured
                neurons in a manner similar to synthetic ADDLs (Lacor et al.,<xref rid="B32" ref-type="bibr">2004</xref>
                ). The implication of these brain-derived dodecamers as pathophysiologically relevant A&#x003b2;
                oligomers is supported by the isolation of a similar 56 kDa oligomer from APP-overexpressing AD
                transgenic mice that was capable of disrupting memory upon injection into young wild type rats (Lesne et
                al.,<xref rid="B37" ref-type="bibr">2006</xref>) At the lower end of the oligomer spectrum a particular
                neurotoxic effect is assigned to dimers and trimers (Hung et al.,<xref rid="B25" ref-type="bibr">
                    2008</xref>; Ono et al.,<xref rid="B49" ref-type="bibr">2009</xref>), which were also found to
                inhibit LTP in hippocampal slices (Shankar et al.,<xref rid="B58" ref-type="bibr">2007</xref>,<xref
                        rid="B59" ref-type="bibr">2008</xref>).
            </p>
            <p>Amyloid oligomers block LTP in hippocampal neurones by binding and cross-linking receptors that are then
                internalized and degraded in the post-synaptic neuron. Drastic neuronal damage also occurs. Loss of
                neuronal density and synapse concentration is a marked characteristic of a post-mortem AD brain, and
                cognition loss can occur when levels of soluble oligomers are high, many months before the appearance of
                senile plaques (Moechars et al.,<xref rid="B45" ref-type="bibr">1999</xref>). Low concentrations (pM) of
                &#x003b2;-amyloid, commensurate with levels found in normal human brain, produced a marked increase in
                LTP in hippocampal slices (Puzzo et al.,<xref rid="B52" ref-type="bibr">2008</xref>), whereas larger
                concentrations (nM) led to a block raising the possibility that the normal function of A&#x003b2; may be
                to modulate synaptic plasticity positively. This finding raises the problem that any therapeutic
                reduction in A&#x003b2; may have to leave trace amounts of A&#x003b2; to function during normal
                development. Indeed, soluble oligomeric forms in aqueous extracts of post-mortem brains from patients
                showing early cognitive loss contained SDS-stable oligomers suggesting their early accumulation in the
                disease process (McLean et al.,<xref rid="B42" ref-type="bibr">1999</xref>).
            </p>
            <p>Direct implications of these and other findings is the necessity of diagnostic detection platforms that
                would be able to capture and detect circulating trace amounts of A&#x003b2; oligomers (Figure<xref
                        ref-type="fig" rid="F2">2</xref>).
            </p>
            <fig id="F2" position="float">
                <label>Figure 2</label>
                <caption>
                    <p><bold>Conceptual schematic of the nanoprobe-based capture of A&#x003b2; oligomers</bold>. A
                        capturing bait conjugated to a gold nanoparticle (yellow) discriminates an A&#x003b2; oligomer
                        in &#x003b2;-sheet conformation (green) from unfolded or folded monomers (blue and red) (PDB
                        entries 1BEG, 2LFM, 2GSP, and 2OTK). (Georganopoulou et al.,<xref rid="B14" ref-type="bibr">
                            2005</xref>; Chikae et al.,<xref rid="B7" ref-type="bibr">2008</xref>; Santos et al.,<xref
                                rid="B57" ref-type="bibr">2008</xref>; Herskovits et al.,<xref rid="B20"
                                                                                               ref-type="bibr">
                            2013</xref>).
                    </p>
                </caption>
                <graphic xlink:href="fchem-03-00017-g0002"/>
            </fig>
        </sec>
        <sec>
            <title>Final remarks on the diagnostic value of A&#x003b2;</title>
            <p>Despite the need and urgency and that all experimental evidence points to the substantial value of A&#x003b2;
                oligomers for early diagnosis and as a possible surrogate biomarker in clinical trials (Sian et al.,
                <xref rid="B60" ref-type="bibr">2000</xref>; Austen et al.,<xref rid="B2" ref-type="bibr">2008</xref>;
                Gao et al.,<xref rid="B13" ref-type="bibr">2010</xref>; Yam et al.,<xref rid="B67" ref-type="bibr">
                    2011</xref>; Herskovits et al.,<xref rid="B20" ref-type="bibr">2013</xref>; Lesne et al.,<xref
                        rid="B36" ref-type="bibr">2013</xref>), A&#x003b2; has yet to be validated as a clinically
                accepted marker for AD (Hampel et al.,<xref rid="B19" ref-type="bibr">2010</xref>; Humpel,<xref
                        rid="B24" ref-type="bibr">2011</xref>; Chintamaneni and Bhaskar,<xref rid="B10" ref-type="bibr">
                    2012</xref>; Rosen et al.,<xref rid="B53" ref-type="bibr">2013</xref>).
            </p>
            <p>Admittedly, the lack of progress in this area is due to the outlined uncertainties of amyloid formation,
                which compromise the very notion of efficient diagnosis as a synergistic balance between specificity and
                the speed of obtaining results. However, given that the post-mortem analysis of
                <italic>ex-vivo</italic>
                brain specimens remains the only definitive AD diagnosis any test able to differentiate soluble
                oligomers at an early pre-fibrillar stage is of significant value and must be tried.
            </p>
            <p>The development of technologies based on conformation-responsive detection of A&#x003b2; is arguably the
                most appealing approach toward this. The diagnostic value of such a strategy is based on direct
                correlations between oligomer amounts and disease progression, but yet again stumbles upon our poor
                understanding of precise conformational states that are responsible for AD. Revealing these
                conformations, transient or stable, may underpin the development of new molecular modalities with
                differentially selective and high affinity profiles to soluble oligomers that can be used as molecular
                sensors or baits enabling the capture of amyloid precursors in biological matrices.
            </p>
            <sec>
                <title>Conflict of interest statement</title>
                <p>The authors declare that the research was conducted in the absence of any commercial or financial
                    relationships that could be construed as a potential conflict of interest.
                </p>
            </sec>
        </sec>
    </body>
    <back>
        <ref-list>
            <title>References</title>
            <ref id="B1">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Armen</surname>
                            <given-names>R. S.</given-names>
                        </name>
                        <name>
                            <surname>Demarco</surname>
                            <given-names>M. L.</given-names>
                        </name>
                        <name>
                            <surname>Alonso</surname>
                            <given-names>D. O.</given-names>
                        </name>
                        <name>
                            <surname>Daggett</surname>
                            <given-names>V.</given-names>
                        </name>
                    </person-group>
                    (<year>2004</year>).<article-title>Pauling and Corey's alpha-pleated sheet structure may define the
                    prefibrillar amyloidogenic intermediate in amyloid disease</article-title>.<source>Proc. Natl. Acad.
                    Sci. U.S.A</source>.<volume>101</volume>,<fpage>11622</fpage>&#x02013;
                    <lpage>11627</lpage>
                    <pub-id pub-id-type="doi">10.1073/pnas.0401781101</pub-id>
                    <pub-id pub-id-type="pmid">15280548</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Austen</surname>
                            <given-names>B. M.</given-names>
                        </name>
                        <name>
                            <surname>Aggrey</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Merh</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Ly</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Lawrence</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Yeong</surname>
                            <given-names>K.</given-names>
                        </name>
                    </person-group>
                    (<year>2008</year>).<article-title>P1-354: a diagnostic ELISA measures higher levels of soluble
                    oligomers of &#x003b2;-amyloid in sera from Alzheimer's patients than age-matched
                    controls</article-title>.<source>Alzheimers Dement. J. Alzheimers Assoc</source>.<volume>4</volume>,
                    <fpage>T322</fpage>
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2008.05.936</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Barghorn</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Nimmrich</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Striebinger</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Krantz</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Keller</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Janson</surname>
                            <given-names>B.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2005</year>).<article-title>Globular amyloid beta-peptide oligomer - a homogenous and
                    stable neuropathological protein in Alzheimer's disease</article-title>.<source>J.
                    Neurochem</source>.<volume>95</volume>,<fpage>834</fpage>&#x02013;<lpage>847</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03407.x</pub-id>
                    <?supplied-pmid 16135089?>
                    <pub-id pub-id-type="pmid">16135089</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B71">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Benilova</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Karran</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>De Strooper</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>The toxic Abeta oligomer and Alzheimer's disease: an emperor in
                    need of clothes</article-title>.<source>Nat. Neurosci</source>.<volume>15</volume>,<fpage>
                    349</fpage>&#x02013;<lpage>357</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nn.3028</pub-id>
                    <?supplied-pmid 22286176?>
                    <pub-id pub-id-type="pmid">22286176</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B4">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bieschke</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Herbst</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Wiglenda</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Friedrich</surname>
                            <given-names>R. P.</given-names>
                        </name>
                        <name>
                            <surname>Boeddrich</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Schiele</surname>
                            <given-names>F.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2012</year>).<article-title>Small-molecule conversion of toxic oligomers to nontoxic
                    beta-sheet-rich amyloid fibrils</article-title>.<source>Nat. Chem. Biol</source>.<volume>8</volume>,
                    <fpage>93</fpage>&#x02013;<lpage>101</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nchembio.719</pub-id>
                    <?supplied-pmid 22101602?>
                    <pub-id pub-id-type="pmid">22101602</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bitan</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Fradinger</surname>
                            <given-names>E. A.</given-names>
                        </name>
                        <name>
                            <surname>Spring</surname>
                            <given-names>S. M.</given-names>
                        </name>
                        <name>
                            <surname>Teplow</surname>
                            <given-names>D. B.</given-names>
                        </name>
                    </person-group>
                    (<year>2005</year>).<article-title>Neurotoxic protein oligomers&#x02014;what you see is not always
                    what you get</article-title>.
                    <source>Amyloid</source>
                    <volume>12</volume>,<fpage>88</fpage>&#x02013;<lpage>95</lpage>.
                    <pub-id pub-id-type="doi">10.1080/13506120500106958</pub-id>
                    <?supplied-pmid 16011984?>
                    <pub-id pub-id-type="pmid">16011984</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Broersen</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Rousseau</surname>
                            <given-names>F.</given-names>
                        </name>
                        <name>
                            <surname>Schymkowitz</surname>
                            <given-names>J.</given-names>
                        </name>
                    </person-group>
                    (<year>2010</year>).
                    <article-title>The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease:
                        oligomer size or conformation?
                    </article-title>
                    <source>Alzheimers. Res. Ther</source>.<volume>2</volume>,<fpage>12</fpage>.
                    <pub-id pub-id-type="doi">10.1186/alzrt36</pub-id>
                    <?supplied-pmid 20642866?>
                    <pub-id pub-id-type="pmid">20642866</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B7">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chikae</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Fukuda</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Kerman</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Idegami</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Miura</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Tamiya</surname>
                            <given-names>E.</given-names>
                        </name>
                    </person-group>
                    (<year>2008</year>).<article-title>Amyloid-beta detection with saccharide immobilized gold
                    nanoparticle on carbon electrode</article-title>.
                    <source>Bioelectrochemistry</source>
                    <volume>74</volume>,<fpage>118</fpage>&#x02013;<lpage>123</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.bioelechem.2008.06.005</pub-id>
                    <?supplied-pmid 18676183?>
                    <pub-id pub-id-type="pmid">18676183</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B8">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chimon</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Ishii</surname>
                            <given-names>Y.</given-names>
                        </name>
                    </person-group>
                    (<year>2005</year>).<article-title>Capturing intermediate structures of Alzheimer's beta-amyloid,
                    Abeta(1-40), by solid-state NMR spectroscopy</article-title>.<source>J. Am. Chem. Soc</source>.
                    <volume>127</volume>,<fpage>13472</fpage>&#x02013;<lpage>13473</lpage>.
                    <pub-id pub-id-type="doi">10.1021/ja054039l</pub-id>
                    <?supplied-pmid 16190691?>
                    <pub-id pub-id-type="pmid">16190691</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B9">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chimon</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Shaibat</surname>
                            <given-names>M. A.</given-names>
                        </name>
                        <name>
                            <surname>Jones</surname>
                            <given-names>C. R.</given-names>
                        </name>
                        <name>
                            <surname>Calero</surname>
                            <given-names>D. C.</given-names>
                        </name>
                        <name>
                            <surname>Aizezi</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Ishii</surname>
                            <given-names>Y.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>Evidence of fibril-like beta-sheet structures in a neurotoxic
                    amyloid intermediate of Alzheimer's beta-amyloid</article-title>.<source>Nat. Struct. Mol.
                    Biol</source>.<volume>14</volume>,<fpage>1157</fpage>&#x02013;<lpage>1164</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nsmb1345</pub-id>
                    <?supplied-pmid 18059284?>
                    <pub-id pub-id-type="pmid">18059284</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chintamaneni</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Bhaskar</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>Biomarkers in Alzheimer's disease: a review</article-title>.
                    <source>ISRN Pharmacol</source>.<volume>2012</volume>:<fpage>984786</fpage>.
                    <pub-id pub-id-type="doi">10.5402/2012/984786</pub-id>
                    <?supplied-pmid 22811931?>
                    <pub-id pub-id-type="pmid">22811931</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Dubnovitsky</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Sandberg</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Rahman</surname>
                            <given-names>M. M.</given-names>
                        </name>
                        <name>
                            <surname>Benilova</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Lendel</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Hard</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>Amyloid-beta protofibrils: size, morphology and synaptotoxicity
                    of an engineered mimic</article-title>.
                    <source>PLoS ONE</source>
                    <volume>8</volume>:<fpage>e66101</fpage>.
                    <pub-id pub-id-type="doi">10.1371/annotation/44be8a39-d943-419b-a430-c2b30dafadec</pub-id>
                    <?supplied-pmid 23843949?>
                    <pub-id pub-id-type="pmid">23843949</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Eisenberg</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Jucker</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>The amyloid state of proteins in human diseases</article-title>.
                    <source>Cell</source>
                    <volume>148</volume>,<fpage>1188</fpage>&#x02013;<lpage>1203</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.022</pub-id>
                    <?supplied-pmid 22424229?>
                    <pub-id pub-id-type="pmid">22424229</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gao</surname>
                            <given-names>C. M.</given-names>
                        </name>
                        <name>
                            <surname>Yam</surname>
                            <given-names>A. Y.</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Magdangal</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Salisbury</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Peretz</surname>
                            <given-names>D.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2010</year>).<article-title>Abeta40 oligomers identified as a potential biomarker for the
                    diagnosis of Alzheimer's disease</article-title>.
                    <source>PLoS ONE</source>
                    <volume>5</volume>:<fpage>e15725</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0015725</pub-id>
                    <?supplied-pmid 21209907?>
                    <pub-id pub-id-type="pmid">21209907</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Georganopoulou</surname>
                            <given-names>D. G.</given-names>
                        </name>
                        <name>
                            <surname>Chang</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Nam</surname>
                            <given-names>J. M.</given-names>
                        </name>
                        <name>
                            <surname>Thaxton</surname>
                            <given-names>C. S.</given-names>
                        </name>
                        <name>
                            <surname>Mufson</surname>
                            <given-names>E. J.</given-names>
                        </name>
                        <name>
                            <surname>Klein</surname>
                            <given-names>W. L.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2005</year>).<article-title>Nanoparticle-based detection in cerebral spinal fluid of a
                    soluble pathogenic biomarker for Alzheimer's disease</article-title>.<source>Proc. Natl. Acad. Sci.
                    U.S.A</source>.<volume>102</volume>,<fpage>2273</fpage>&#x02013;<lpage>2276</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.0409336102</pub-id>
                    <?supplied-pmid 15695586?>
                    <pub-id pub-id-type="pmid">15695586</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B15">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gillam</surname>
                            <given-names>J. E.</given-names>
                        </name>
                        <name>
                            <surname>MacPhee</surname>
                            <given-names>C. E.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>Modelling amyloid fibril formation kinetics: mechanisms of
                    nucleation and growth</article-title>.
                    <source>J. Phys. Condens. Matter</source>
                    <volume>25</volume>:<fpage>373101</fpage>.
                    <pub-id pub-id-type="doi">10.1088/0953-8984/25/37/373101</pub-id>
                    <?supplied-pmid 23941964?>
                    <pub-id pub-id-type="pmid">23941964</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Glabe</surname>
                            <given-names>C. G.</given-names>
                        </name>
                    </person-group>
                    (<year>2008</year>).<article-title>Structural classification of toxic amyloid
                    oligomers</article-title>.<source>J. Biol. Chem</source>.<volume>283</volume>,<fpage>29639</fpage>
                    &#x02013;<lpage>29643</lpage>.
                    <pub-id pub-id-type="doi">10.1074/jbc.R800016200</pub-id>
                    <?supplied-pmid 18723507?>
                    <pub-id pub-id-type="pmid">18723507</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B17">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Glenner</surname>
                            <given-names>G. G.</given-names>
                        </name>
                        <name>
                            <surname>Wong</surname>
                            <given-names>C. W.</given-names>
                        </name>
                    </person-group>
                    (<year>1984</year>).<article-title>Alzheimer's disease: initial report of the purification and
                    characterization of a novel cerebrovascular amyloid protein</article-title>.<source>Biochem.
                    Biophys. Res. Commun</source>.<volume>120</volume>,<fpage>885</fpage>&#x02013;<lpage>890</lpage>.
                    <pub-id pub-id-type="doi">10.1016/S0006-291X(84)80190-4</pub-id>
                    <?supplied-pmid 6375662?>
                    <pub-id pub-id-type="pmid">6375662</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Haass</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Selkoe</surname>
                            <given-names>D. J.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>Soluble protein oligomers in neurodegeneration: lessons from the
                    Alzheimer's amyloid beta-peptide</article-title>.<source>Nat. Rev. Mol. Cell Biol</source>.<volume>
                    8</volume>,<fpage>101</fpage>&#x02013;<lpage>112</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nrm2101</pub-id>
                    <?supplied-pmid 17245412?>
                    <pub-id pub-id-type="pmid">17245412</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hampel</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Frank</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Broich</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Teipel</surname>
                            <given-names>S. J.</given-names>
                        </name>
                        <name>
                            <surname>Katz</surname>
                            <given-names>R. G.</given-names>
                        </name>
                        <name>
                            <surname>Hardy</surname>
                            <given-names>J.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2010</year>).<article-title>Biomarkers for Alzheimer's disease: academic, industry and
                    regulatory perspectives</article-title>.<source>Nat. Rev. Drug Discov</source>.<volume>9</volume>,
                    <fpage>560</fpage>&#x02013;<lpage>574</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nrd3115</pub-id>
                    <?supplied-pmid 20592748?>
                    <pub-id pub-id-type="pmid">20592748</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B20">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Herskovits</surname>
                            <given-names>A. Z.</given-names>
                        </name>
                        <name>
                            <surname>Locascio</surname>
                            <given-names>J. J.</given-names>
                        </name>
                        <name>
                            <surname>Peskind</surname>
                            <given-names>E. R.</given-names>
                        </name>
                        <name>
                            <surname>Li</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Hyman</surname>
                            <given-names>B. T.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>A Luminex assay detects amyloid beta oligomers in Alzheimer's
                    disease cerebrospinal fluid</article-title>.
                    <source>PLoS ONE</source>
                    <volume>8</volume>:<fpage>e67898</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0067898</pub-id>
                    <?supplied-pmid 23844122?>
                    <pub-id pub-id-type="pmid">23844122</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B21">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hopping</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Kellock</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Barnwal</surname>
                            <given-names>R. P.</given-names>
                        </name>
                        <name>
                            <surname>Law</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Bryers</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Varani</surname>
                            <given-names>G.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2014</year>).<article-title>Designed alpha-sheet peptides inhibit amyloid formation by
                    targeting toxic oligomers</article-title>.
                    <source>Elife</source>
                    <volume>3</volume>:<fpage>e01681</fpage>.
                    <pub-id pub-id-type="doi">10.7554/eLife.01681</pub-id>
                    <?supplied-pmid 25027691?>
                    <pub-id pub-id-type="pmid">25027691</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B22">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hoshi</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Sato</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Matsumoto</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Noguchi</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Yasutake</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Yoshida</surname>
                            <given-names>N.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2003</year>).<article-title>Spherical aggregates of beta-amyloid (amylospheroid) show high
                    neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta</article-title>.
                    <source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>100</volume>,<fpage>6370</fpage>&#x02013;
                    <lpage>6375</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.1237107100</pub-id>
                    <?supplied-pmid 12750461?>
                    <pub-id pub-id-type="pmid">12750461</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B23">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hubin</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>van Nuland</surname>
                            <given-names>N. A.</given-names>
                        </name>
                        <name>
                            <surname>Broersen</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Pauwels</surname>
                            <given-names>K.</given-names>
                        </name>
                    </person-group>
                    (<year>2014</year>).<article-title>Transient dynamics of Abeta contribute to toxicity in Alzheimer's
                    disease</article-title>.<source>Cell. Mol. Life Sci</source>.<volume>71</volume>,<fpage>3507</fpage>
                    &#x02013;<lpage>3521</lpage>.
                    <pub-id pub-id-type="doi">10.1007/s00018-014-1634-z</pub-id>
                    <?supplied-pmid 24803005?>
                    <pub-id pub-id-type="pmid">24803005</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B24">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Humpel</surname>
                            <given-names>C.</given-names>
                        </name>
                    </person-group>
                    (<year>2011</year>).<article-title>Identifying and validating biomarkers for Alzheimer's
                    disease</article-title>.<source>Trends Biotechnol</source>.<volume>29</volume>,<fpage>26</fpage>
                    &#x02013;<lpage>32</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.tibtech.2010.09.007</pub-id>
                    <?supplied-pmid 20971518?>
                    <pub-id pub-id-type="pmid">20971518</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B25">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hung</surname>
                            <given-names>L. W.</given-names>
                        </name>
                        <name>
                            <surname>Ciccotosto</surname>
                            <given-names>G. D.</given-names>
                        </name>
                        <name>
                            <surname>Giannakis</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Tew</surname>
                            <given-names>D. J.</given-names>
                        </name>
                        <name>
                            <surname>Perez</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Masters</surname>
                            <given-names>C. L.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2008</year>).<article-title>Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the
                    rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity</article-title>.
                    <source>J. Neurosci</source>.<volume>28</volume>,<fpage>11950</fpage>&#x02013;<lpage>11958</lpage>.
                    <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3916-08.2008</pub-id>
                    <?supplied-pmid 19005060?>
                    <pub-id pub-id-type="pmid">19005060</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B26">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jiang</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Leibly</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Landau</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Hughes</surname>
                            <given-names>M. P.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2013</year>).<article-title>Structure-based discovery of fiber-binding compounds that
                    reduce the cytotoxicity of amyloid beta</article-title>.
                    <source>Elife</source>
                    <volume>2</volume>,<fpage>e00857</fpage>.
                    <pub-id pub-id-type="doi">10.7554/eLife.00857</pub-id>
                    <?supplied-pmid 23878726?>
                    <pub-id pub-id-type="pmid">23878726</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B27">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kahler</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Sticht</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Horn</surname>
                            <given-names>A. H.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>Conformational stability of fibrillar amyloid-beta oligomers via
                    protofilament pair formation - a systematic computational study</article-title>.
                    <source>PLoS ONE</source>
                    <volume>8</volume>:<fpage>e70521</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0070521</pub-id>
                    <?supplied-pmid 23936224?>
                    <pub-id pub-id-type="pmid">23936224</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B28">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kajava</surname>
                            <given-names>A. V.</given-names>
                        </name>
                        <name>
                            <surname>Baxa</surname>
                            <given-names>U.</given-names>
                        </name>
                        <name>
                            <surname>Steven</surname>
                            <given-names>A. C.</given-names>
                        </name>
                    </person-group>
                    (<year>2010</year>).<article-title>Beta arcades: recurring motifs in naturally occurring and
                    disease-related amyloid fibrils</article-title>.<source>FASEB J</source>.<volume>24</volume>,<fpage>
                    1311</fpage>&#x02013;<lpage>1319</lpage>.
                    <pub-id pub-id-type="doi">10.1096/fj.09-145979</pub-id>
                    <?supplied-pmid 20032312?>
                    <pub-id pub-id-type="pmid">20032312</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B29">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kayed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Head</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Sarsoza</surname>
                            <given-names>F.</given-names>
                        </name>
                        <name>
                            <surname>Saing</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Cotman</surname>
                            <given-names>C. W.</given-names>
                        </name>
                        <name>
                            <surname>Necula</surname>
                            <given-names>M.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2007</year>).<article-title>Fibril specific, conformation dependent antibodies recognize a
                    generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar
                    oligomers</article-title>.<source>Mol. Neurodegener</source>.<volume>2</volume>:<fpage>18</fpage>.
                    <pub-id pub-id-type="doi">10.1186/1750-1326-2-18</pub-id>
                    <?supplied-pmid 17897471?>
                    <pub-id pub-id-type="pmid">17897471</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B30">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kayed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Head</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Thompson</surname>
                            <given-names>J. L.</given-names>
                        </name>
                        <name>
                            <surname>McIntire</surname>
                            <given-names>T. M.</given-names>
                        </name>
                        <name>
                            <surname>Milton</surname>
                            <given-names>S. C.</given-names>
                        </name>
                        <name>
                            <surname>Cotman</surname>
                            <given-names>C. W.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2003</year>).<article-title>Common structure of soluble amyloid oligomers implies common
                    mechanism of pathogenesis</article-title>.
                    <source>Science</source>
                    <volume>300</volume>,<fpage>486</fpage>&#x02013;<lpage>489</lpage>.
                    <pub-id pub-id-type="doi">10.1126/science.1079469</pub-id>
                    <?supplied-pmid 12702875?>
                    <pub-id pub-id-type="pmid">12702875</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B31">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kayed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Lasagna-Reeves</surname>
                            <given-names>C. A.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>Molecular mechanisms of amyloid oligomers
                    toxicity</article-title>.<source>J. Alzheimers. Dis</source>.
                    <volume>33</volume>
                    <issue>Suppl. 1</issue>,<fpage>S67</fpage>&#x02013;<lpage>S78</lpage>.
                    <pub-id pub-id-type="doi">10.3233/JAD-2012-129001</pub-id>
                    <?supplied-pmid 22531422?>
                    <pub-id pub-id-type="pmid">22531422</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B32">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lacor</surname>
                            <given-names>P. N.</given-names>
                        </name>
                        <name>
                            <surname>Buniel</surname>
                            <given-names>M. C.</given-names>
                        </name>
                        <name>
                            <surname>Chang</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Fernandez</surname>
                            <given-names>S. J.</given-names>
                        </name>
                        <name>
                            <surname>Gong</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Viola</surname>
                            <given-names>K. L.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2004</year>).<article-title>Synaptic targeting by Alzheimer's-related amyloid beta
                    oligomers</article-title>.<source>J. Neurosci</source>.<volume>24</volume>,<fpage>10191</fpage>
                    &#x02013;<lpage>10200</lpage>.
                    <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3432-04.2004</pub-id>
                    <?supplied-pmid 15537891?>
                    <pub-id pub-id-type="pmid">15537891</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B33">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ladiwala</surname>
                            <given-names>A. R.</given-names>
                        </name>
                        <name>
                            <surname>Litt</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Kane</surname>
                            <given-names>R. S.</given-names>
                        </name>
                        <name>
                            <surname>Aucoin</surname>
                            <given-names>D. S.</given-names>
                        </name>
                        <name>
                            <surname>Smith</surname>
                            <given-names>S. O.</given-names>
                        </name>
                        <name>
                            <surname>Ranjan</surname>
                            <given-names>S.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2012</year>).<article-title>Conformational differences between two amyloid beta oligomers
                    of similar size and dissimilar toxicity</article-title>.<source>J. Biol. Chem</source>.<volume>
                    287</volume>,<fpage>24765</fpage>&#x02013;<lpage>24773</lpage>.
                    <pub-id pub-id-type="doi">10.1074/jbc.M111.329763</pub-id>
                    <?supplied-pmid 22547072?>
                    <pub-id pub-id-type="pmid">22547072</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B34">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lambert</surname>
                            <given-names>M. P.</given-names>
                        </name>
                        <name>
                            <surname>Barlow</surname>
                            <given-names>A. K.</given-names>
                        </name>
                        <name>
                            <surname>Chromy</surname>
                            <given-names>B. A.</given-names>
                        </name>
                        <name>
                            <surname>Edwards</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Freed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Liosatos</surname>
                            <given-names>M.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>1998</year>).<article-title>Diffusible, nonfibrillar ligands derived from Abeta1-42 are
                    potent central nervous system neurotoxins</article-title>.<source>Proc. Natl. Acad. Sci.
                    U.S.A</source>.<volume>95</volume>,<fpage>6448</fpage>&#x02013;<lpage>6453</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.95.11.6448</pub-id>
                    <?supplied-pmid 9600986?>
                    <pub-id pub-id-type="pmid">9600986</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B35">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Fernandez</surname>
                            <given-names>E. J.</given-names>
                        </name>
                        <name>
                            <surname>Good</surname>
                            <given-names>T. A.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>Role of aggregation conditions in structure, stability, and
                    toxicity of intermediates in the Abeta fibril formation pathway</article-title>.<source>Protein
                    Sci</source>.<volume>16</volume>,<fpage>723</fpage>&#x02013;<lpage>732</lpage>.
                    <pub-id pub-id-type="doi">10.1110/ps.062514807</pub-id>
                    <?supplied-pmid 17327396?>
                    <pub-id pub-id-type="pmid">17327396</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B36">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lesne</surname>
                            <given-names>S. E.</given-names>
                        </name>
                        <name>
                            <surname>Sherman</surname>
                            <given-names>M. A.</given-names>
                        </name>
                        <name>
                            <surname>Grant</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Kuskowski</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Schneider</surname>
                            <given-names>J. A.</given-names>
                        </name>
                        <name>
                            <surname>Bennett</surname>
                            <given-names>D. A.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2013</year>).<article-title>Brain amyloid-beta oligomers in ageing and Alzheimer's
                    disease</article-title>.
                    <source>Brain</source>
                    <volume>136</volume>,<fpage>1383</fpage>&#x02013;<lpage>1398</lpage>.
                    <pub-id pub-id-type="doi">10.1093/brain/awt062</pub-id>
                    <?supplied-pmid 23576130?>
                    <pub-id pub-id-type="pmid">23576130</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B37">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lesne</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Koh</surname>
                            <given-names>M. T.</given-names>
                        </name>
                        <name>
                            <surname>Kotilinek</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Kayed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Glabe</surname>
                            <given-names>C. G.</given-names>
                        </name>
                        <name>
                            <surname>Yang</surname>
                            <given-names>A.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2006</year>).<article-title>A specific amyloid-beta protein assembly in the brain impairs
                    memory</article-title>.
                    <source>Nature</source>
                    <volume>440</volume>,<fpage>352</fpage>&#x02013;<lpage>357</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nature04533</pub-id>
                    <?supplied-pmid 16541076?>
                    <pub-id pub-id-type="pmid">16541076</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B38">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Jiang</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Cheng</surname>
                            <given-names>P. N.</given-names>
                        </name>
                        <name>
                            <surname>Park</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Sawaya</surname>
                            <given-names>M. R.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2012</year>).<article-title>Out-of-register beta-sheets suggest a pathway to toxic amyloid
                    aggregates</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>109</volume>,
                    <fpage>20913</fpage>&#x02013;<lpage>20918</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.1218792109</pub-id>
                    <?supplied-pmid 23213214?>
                    <pub-id pub-id-type="pmid">23213214</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B39">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Marshall</surname>
                            <given-names>K. E. S. L. C.</given-names>
                        </name>
                    </person-group>
                    (<year>2009</year>).<article-title>Insights into the structure of amyloid fibrils</article-title>.
                    <source>Open Biol. J</source>.<volume>2</volume>,<fpage>185</fpage>&#x02013;
                    <lpage>192</lpage>
                    <pub-id pub-id-type="doi">10.2174/1874196700902020185</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B40">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Martin</surname>
                            <given-names>S. J.</given-names>
                        </name>
                        <name>
                            <surname>Grimwood</surname>
                            <given-names>P. D.</given-names>
                        </name>
                        <name>
                            <surname>Morris</surname>
                            <given-names>R. G.</given-names>
                        </name>
                    </person-group>
                    (<year>2000</year>).<article-title>Synaptic plasticity and memory: an evaluation of the
                    hypothesis</article-title>.<source>Annu. Rev. Neurosci</source>.<volume>23</volume>,<fpage>
                    649</fpage>&#x02013;<lpage>711</lpage>.
                    <pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.649</pub-id>
                    <?supplied-pmid 10845078?>
                    <pub-id pub-id-type="pmid">10845078</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B41">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Masters</surname>
                            <given-names>C. L.</given-names>
                        </name>
                        <name>
                            <surname>Simms</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Weinman</surname>
                            <given-names>N. A.</given-names>
                        </name>
                        <name>
                            <surname>Multhaup</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>McDonald</surname>
                            <given-names>B. L.</given-names>
                        </name>
                        <name>
                            <surname>Beyreuther</surname>
                            <given-names>K.</given-names>
                        </name>
                    </person-group>
                    (<year>1985</year>).<article-title>Amyloid plaque core protein in Alzheimer disease and Down
                    syndrome</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>82</volume>,<fpage>
                    4245</fpage>&#x02013;<lpage>4249</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.82.12.4245</pub-id>
                    <?supplied-pmid 3159021?>
                    <pub-id pub-id-type="pmid">3159021</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B42">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>McLean</surname>
                            <given-names>C. A.</given-names>
                        </name>
                        <name>
                            <surname>Cherny</surname>
                            <given-names>R. A.</given-names>
                        </name>
                        <name>
                            <surname>Fraser</surname>
                            <given-names>F. W.</given-names>
                        </name>
                        <name>
                            <surname>Fuller</surname>
                            <given-names>S. J.</given-names>
                        </name>
                        <name>
                            <surname>Smith</surname>
                            <given-names>M. J.</given-names>
                        </name>
                        <name>
                            <surname>Beyreuther</surname>
                            <given-names>K.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>1999</year>).<article-title>Soluble pool of Abeta amyloid as a determinant of severity of
                    neurodegeneration in Alzheimer's disease</article-title>.<source>Ann. Neurol</source>.<volume>
                    46</volume>,<fpage>860</fpage>&#x02013;<lpage>866</lpage>. <?supplied-pmid 10589538?>
                    <pub-id pub-id-type="pmid">10589538</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B43">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Meli</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Lecci</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Manca</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Krako</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Albertini</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Benussi</surname>
                            <given-names>L.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    (<year>2014</year>).<article-title>Conformational targeting of intracellular Abeta oligomers
                    demonstrates their pathological oligomerization inside the endoplasmic reticulum</article-title>.
                    <source>Nat. Commun</source>.<volume>5</volume>,
                    <fpage>3867</fpage>
                    <pub-id pub-id-type="doi">10.1038/ncomms4867</pub-id>
                    <pub-id pub-id-type="pmid">24861166</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B44">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Miller</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Ma</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Nussinov</surname>
                            <given-names>R.</given-names>
                        </name>
                    </person-group>
                    (<year>2010</year>).<article-title>Polymorphism in Alzheimer Abeta amyloid organization reflects
                    conformational selection in a rugged energy landscape</article-title>.<source>Chem. Rev</source>.
                    <volume>110</volume>,<fpage>4820</fpage>&#x02013;<lpage>4838</lpage>.
                    <pub-id pub-id-type="doi">10.1021/cr900377t</pub-id>
                    <?supplied-pmid 20402519?>
                    <pub-id pub-id-type="pmid">20402519</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B45">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Moechars</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Dewachter</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Lorent</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Reverse</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Baekelandt</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Naidu</surname>
                            <given-names>A.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>1999</year>).<article-title>Early phenotypic changes in transgenic mice that overexpress
                    different mutants of amyloid precursor protein in brain</article-title>.<source>J. Biol.
                    Chem</source>.<volume>274</volume>,<fpage>6483</fpage>&#x02013;<lpage>6492</lpage>.
                    <pub-id pub-id-type="doi">10.1074/jbc.274.10.6483</pub-id>
                    <?supplied-pmid 10037741?>
                    <pub-id pub-id-type="pmid">10037741</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B46">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mucke</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Selkoe</surname>
                            <given-names>D. J.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>Neurotoxicity of amyloid beta-protein: synaptic and network
                    dysfunction</article-title>.<source>Cold Spring Harb. Perspect. Med</source>.<volume>2</volume>:
                    <fpage>a006338</fpage>.
                    <pub-id pub-id-type="doi">10.1101/cshperspect.a006338</pub-id>
                    <?supplied-pmid 22762015?>
                    <pub-id pub-id-type="pmid">22762015</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B47">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Necula</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Kayed</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Milton</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Glabe</surname>
                            <given-names>C. G.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>Small molecule inhibitors of aggregation indicate that amyloid
                    beta oligomerization and fibrillization pathways are independent and distinct</article-title>.
                    <source>J. Biol. Chem</source>.<volume>282</volume>,<fpage>10311</fpage>&#x02013;<lpage>
                    10324</lpage>.
                    <pub-id pub-id-type="doi">10.1074/jbc.M608207200</pub-id>
                    <?supplied-pmid 17284452?>
                    <pub-id pub-id-type="pmid">17284452</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B48">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Olejniczak</surname>
                            <given-names>E. T.</given-names>
                        </name>
                        <name>
                            <surname>Yu</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Edalji</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Harlan</surname>
                            <given-names>J. E.</given-names>
                        </name>
                        <name>
                            <surname>Holzman</surname>
                            <given-names>T. F.</given-names>
                        </name>
                        <name>
                            <surname>Lopez</surname>
                            <given-names>A. P.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    (<year>2008</year>).<article-title>P2-483: biophysical characterization of soluble amyloid-[beta]
                    peptide oligomers</article-title>.<source>Alzheimers Dement</source>.<volume>4</volume>,<fpage>
                    T516</fpage>&#x02013;
                    <lpage>T516</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2008.05.1561</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B49">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ono</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Condron</surname>
                            <given-names>M. M.</given-names>
                        </name>
                        <name>
                            <surname>Teplow</surname>
                            <given-names>D. B.</given-names>
                        </name>
                    </person-group>
                    (<year>2009</year>).<article-title>Structure-neurotoxicity relationships of amyloid beta-protein
                    oligomers</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>106</volume>,<fpage>
                    14745</fpage>&#x02013;<lpage>14750</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.0905127106</pub-id>
                    <?supplied-pmid 19706468?>
                    <pub-id pub-id-type="pmid">19706468</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B50">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pauling</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Corey</surname>
                            <given-names>R. B.</given-names>
                        </name>
                    </person-group>
                    (<year>1951</year>).<article-title>The pleated sheet, a new layer configuration of polypeptide
                    chains</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>37</volume>,<fpage>
                    251</fpage>&#x02013;<lpage>256</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.37.5.251</pub-id>
                    <?supplied-pmid 14834147?>
                    <pub-id pub-id-type="pmid">14834147</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B51">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Philo</surname>
                            <given-names>J. S.</given-names>
                        </name>
                    </person-group>
                    (<year>2006</year>).
                    <article-title>Is any measurement method optimal for all aggregate sizes and types?</article-title>
                    <source>AAPS J</source>.<volume>8</volume>,<fpage>E564</fpage>&#x02013;<lpage>E571</lpage>.
                    <pub-id pub-id-type="doi">10.1208/aapsj080365</pub-id>
                    <?supplied-pmid 17025274?>
                    <pub-id pub-id-type="pmid">17025274</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B52">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Puzzo</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Privitera</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Leznik</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Fa</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Staniszewski</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Palmeri</surname>
                            <given-names>A.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2008</year>).<article-title>Picomolar amyloid-beta positively modulates synaptic plasticity
                    and memory in hippocampus</article-title>.<source>J. Neurosci</source>.<volume>28</volume>,<fpage>
                    14537</fpage>&#x02013;<lpage>14545</lpage>.
                    <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2692-08.2008</pub-id>
                    <?supplied-pmid 19118188?>
                    <pub-id pub-id-type="pmid">19118188</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B53">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Rosen</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Hansson</surname>
                            <given-names>O.</given-names>
                        </name>
                        <name>
                            <surname>Blennow</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Zetterberg</surname>
                            <given-names>H.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>Fluid biomarkers in Alzheimer's disease - current
                    concepts</article-title>.<source>Mol. Neurodegener</source>.<volume>8</volume>:<fpage>20</fpage>.
                    <pub-id pub-id-type="doi">10.1186/1750-1326-8-20</pub-id>
                    <?supplied-pmid 23800368?>
                    <pub-id pub-id-type="pmid">23800368</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B54">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Russell</surname>
                            <given-names>C. L.</given-names>
                        </name>
                        <name>
                            <surname>Semerdjieva</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Empson</surname>
                            <given-names>R. M.</given-names>
                        </name>
                        <name>
                            <surname>Austen</surname>
                            <given-names>B. M.</given-names>
                        </name>
                        <name>
                            <surname>Beesley</surname>
                            <given-names>P. W.</given-names>
                        </name>
                        <name>
                            <surname>Alifragis</surname>
                            <given-names>P.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>Amyloid-beta acts as a regulator of neurotransmitter release
                    disrupting the interaction between synaptophysin and VAMP2</article-title>.
                    <source>PLoS ONE</source>
                    <volume>7</volume>:<fpage>e43201</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0043201</pub-id>
                    <?supplied-pmid 22905234?>
                    <pub-id pub-id-type="pmid">22905234</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B55">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sakono</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Zako</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    (<year>2010</year>).<article-title>Amyloid oligomers: formation and toxicity of Abeta
                    oligomers</article-title>.<source>FEBS J</source>.<volume>277</volume>,<fpage>1348</fpage>&#x02013;
                    <lpage>1358</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07568.x</pub-id>
                    <?supplied-pmid 20148964?>
                    <pub-id pub-id-type="pmid">20148964</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B56">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sandberg</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Luheshi</surname>
                            <given-names>L. M.</given-names>
                        </name>
                        <name>
                            <surname>Sollvander</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Pereira de Barros</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Macao</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Knowles</surname>
                            <given-names>T. P.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2010</year>).<article-title>Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by
                    protein engineering</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A</source>.<volume>
                    107</volume>,<fpage>15595</fpage>&#x02013;<lpage>15600</lpage>.
                    <pub-id pub-id-type="doi">10.1073/pnas.1001740107</pub-id>
                    <?supplied-pmid 20713699?>
                    <pub-id pub-id-type="pmid">20713699</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B57">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Santos</surname>
                            <given-names>A. N.</given-names>
                        </name>
                        <name>
                            <surname>Simm</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Holthoff</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Boehm</surname>
                            <given-names>G.</given-names>
                        </name>
                    </person-group>
                    (<year>2008</year>).<article-title>A method for the detection of amyloid-beta1-40, amyloid-beta1-42
                    and amyloid-beta oligomers in blood using magnetic beads in combination with Flow cytometry and its
                    application in the diagnostics of Alzheimer's disease</article-title>.<source>J. Alzheimers
                    Dis</source>.<volume>14</volume>,<fpage>127</fpage>&#x02013;<lpage>131</lpage>
                    . <?supplied-pmid 18560125?>
                    <pub-id pub-id-type="pmid">18560125</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B58">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Shankar</surname>
                            <given-names>G. M.</given-names>
                        </name>
                        <name>
                            <surname>Bloodgood</surname>
                            <given-names>B. L.</given-names>
                        </name>
                        <name>
                            <surname>Townsend</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Walsh</surname>
                            <given-names>D. M.</given-names>
                        </name>
                        <name>
                            <surname>Selkoe</surname>
                            <given-names>D. J.</given-names>
                        </name>
                        <name>
                            <surname>Sabatini</surname>
                            <given-names>B. L.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>Natural oligomers of the Alzheimer amyloid-beta protein induce
                    reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling
                    pathway</article-title>.<source>J. Neurosci</source>.<volume>27</volume>,<fpage>2866</fpage>
                    &#x02013;<lpage>2875</lpage>.
                    <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4970-06.2007</pub-id>
                    <?supplied-pmid 17360908?>
                    <pub-id pub-id-type="pmid">17360908</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B59">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Shankar</surname>
                            <given-names>G. M.</given-names>
                        </name>
                        <name>
                            <surname>Li</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Mehta</surname>
                            <given-names>T. H.</given-names>
                        </name>
                        <name>
                            <surname>Garcia-Munoz</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Shepardson</surname>
                            <given-names>N. E.</given-names>
                        </name>
                        <name>
                            <surname>Smith</surname>
                            <given-names>I.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2008</year>).<article-title>Amyloid-beta protein dimers isolated directly from Alzheimer's
                    brains impair synaptic plasticity and memory</article-title>.<source>Nat. Med</source>.<volume>
                    14</volume>,<fpage>837</fpage>&#x02013;<lpage>842</lpage>.
                    <pub-id pub-id-type="doi">10.1038/nm1782</pub-id>
                    <?supplied-pmid 18568035?>
                    <pub-id pub-id-type="pmid">18568035</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B60">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sian</surname>
                            <given-names>A. K.</given-names>
                        </name>
                        <name>
                            <surname>Frears</surname>
                            <given-names>E. R.</given-names>
                        </name>
                        <name>
                            <surname>El-Agnaf</surname>
                            <given-names>O. M.</given-names>
                        </name>
                        <name>
                            <surname>Patel</surname>
                            <given-names>B. P.</given-names>
                        </name>
                        <name>
                            <surname>Manca</surname>
                            <given-names>M. F.</given-names>
                        </name>
                        <name>
                            <surname>Siligardi</surname>
                            <given-names>G.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2000</year>).<article-title>Oligomerization of beta-amyloid of the Alzheimer's and the
                    Dutch-cerebral-haemorrhage types</article-title>.<source>Biochem. J</source>.<volume>349</volume>,
                    <fpage>299</fpage>&#x02013;<lpage>308</lpage>.
                    <pub-id pub-id-type="doi">10.1042/0264-6021:3490299</pub-id>
                    <?supplied-pmid 10861242?>
                    <pub-id pub-id-type="pmid">10861242</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B61">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Stefani</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    (<year>2012</year>).<article-title>Structural features and cytotoxicity of amyloid oligomers:
                    implications in Alzheimer's disease and other diseases with amyloid deposits</article-title>.
                    <source>Prog. Neurobiol</source>.<volume>99</volume>,<fpage>226</fpage>&#x02013;<lpage>245</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.03.002</pub-id>
                    <?supplied-pmid 22450705?>
                    <pub-id pub-id-type="pmid">22450705</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B62">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tay</surname>
                            <given-names>W. M.</given-names>
                        </name>
                        <name>
                            <surname>Huang</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Rosenberry</surname>
                            <given-names>T. L.</given-names>
                        </name>
                        <name>
                            <surname>Paravastu</surname>
                            <given-names>A. K.</given-names>
                        </name>
                    </person-group>
                    (<year>2013</year>).<article-title>The Alzheimer's amyloid-beta(1-42) peptide forms off-pathway
                    oligomers and fibrils that are distinguished structurally by intermolecular
                    organization</article-title>.<source>J. Mol. Biol</source>.<volume>425</volume>,<fpage>2494</fpage>
                    &#x02013;<lpage>2508</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jmb.2013.04.003</pub-id>
                    <?supplied-pmid 23583777?>
                    <pub-id pub-id-type="pmid">23583777</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B63">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tomic</surname>
                            <given-names>J. L.</given-names>
                        </name>
                        <name>
                            <surname>Pensalfini</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Head</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Glabe</surname>
                            <given-names>C. G.</given-names>
                        </name>
                    </person-group>
                    (<year>2009</year>).<article-title>Soluble fibrillar oligomer levels are elevated in Alzheimer's
                    disease brain and correlate with cognitive dysfunction</article-title>.<source>Neurobiol.
                    Dis</source>.<volume>35</volume>,<fpage>352</fpage>&#x02013;<lpage>358</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.nbd.2009.05.024</pub-id>
                    <?supplied-pmid 19523517?>
                    <pub-id pub-id-type="pmid">19523517</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B64">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Walsh</surname>
                            <given-names>D. M.</given-names>
                        </name>
                        <name>
                            <surname>Klyubin</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Fadeeva</surname>
                            <given-names>J. V.</given-names>
                        </name>
                        <name>
                            <surname>Cullen</surname>
                            <given-names>W. K.</given-names>
                        </name>
                        <name>
                            <surname>Anwyl</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Wolfe</surname>
                            <given-names>M. S.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2002</year>).
                    <article-title>Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal
                        long-term potentiation
                        <italic>in vivo</italic>
                    </article-title>
                    .
                    <source>Nature</source>
                    <volume>416</volume>,<fpage>535</fpage>&#x02013;<lpage>539</lpage>.
                    <pub-id pub-id-type="doi">10.1038/416535a</pub-id>
                    <?supplied-pmid 11932745?>
                    <pub-id pub-id-type="pmid">11932745</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B65">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Walsh</surname>
                            <given-names>D. M.</given-names>
                        </name>
                        <name>
                            <surname>Selkoe</surname>
                            <given-names>D. J.</given-names>
                        </name>
                    </person-group>
                    (<year>2007</year>).<article-title>A beta oligomers - a decade of discovery</article-title>.<source>
                    J. Neurochem</source>.<volume>101</volume>,<fpage>1172</fpage>&#x02013;<lpage>1184</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04426.x</pub-id>
                    <?supplied-pmid 17286590?>
                    <pub-id pub-id-type="pmid">17286590</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B66">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Westlind-Danielsson</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Arnerup</surname>
                            <given-names>G.</given-names>
                        </name>
                    </person-group>
                    (<year>2001</year>).
                    <article-title>Spontaneous
                        <italic>in vitro</italic>
                        formation of supramolecular beta-amyloid structures, &#x0201c;betaamy balls,&#x0201d; by
                        beta-amyloid 1-40 peptide
                    </article-title>
                    .
                    <source>Biochemistry</source>
                    <volume>40</volume>,<fpage>14736</fpage>&#x02013;<lpage>14743</lpage>.
                    <pub-id pub-id-type="doi">10.1021/bi010375c</pub-id>
                    <?supplied-pmid 11732892?>
                    <pub-id pub-id-type="pmid">11732892</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B67">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yam</surname>
                            <given-names>A. Y.</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Gao</surname>
                            <given-names>C. M.</given-names>
                        </name>
                        <name>
                            <surname>Connolly</surname>
                            <given-names>M. D.</given-names>
                        </name>
                        <name>
                            <surname>Zuckermann</surname>
                            <given-names>R. N.</given-names>
                        </name>
                        <name>
                            <surname>Bleu</surname>
                            <given-names>T.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2011</year>).<article-title>A universal method for detection of amyloidogenic misfolded
                    proteins</article-title>.
                    <source>Biochemistry</source>
                    <volume>50</volume>,<fpage>4322</fpage>&#x02013;<lpage>4329</lpage>.
                    <pub-id pub-id-type="doi">10.1021/bi200215j</pub-id>
                    <?supplied-pmid 21539296?>
                    <pub-id pub-id-type="pmid">21539296</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B68">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yoshiike</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Minai</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Matsuo</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Chen</surname>
                            <given-names>Y. R.</given-names>
                        </name>
                        <name>
                            <surname>Kimura</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Takashima</surname>
                            <given-names>A.</given-names>
                        </name>
                    </person-group>
                    (<year>2008</year>).<article-title>Amyloid oligomer conformation in a group of natively folded
                    proteins</article-title>.
                    <source>PLoS ONE</source>
                    <volume>3</volume>:<fpage>e3235</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0003235</pub-id>
                    <?supplied-pmid 18800165?>
                    <pub-id pub-id-type="pmid">18800165</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B69">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yu</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Edalji</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Harlan</surname>
                            <given-names>J. E.</given-names>
                        </name>
                        <name>
                            <surname>Holzman</surname>
                            <given-names>T. F.</given-names>
                        </name>
                        <name>
                            <surname>Lopez</surname>
                            <given-names>A. P.</given-names>
                        </name>
                        <name>
                            <surname>Labkovsky</surname>
                            <given-names>B.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2009</year>).<article-title>Structural characterization of a soluble amyloid beta-peptide
                    oligomer</article-title>.
                    <source>Biochemistry</source>
                    <volume>48</volume>,<fpage>1870</fpage>&#x02013;<lpage>1877</lpage>.
                    <pub-id pub-id-type="doi">10.1021/bi802046n</pub-id>
                    <?supplied-pmid 19216516?>
                    <pub-id pub-id-type="pmid">19216516</pub-id>
                </mixed-citation>
            </ref>
            <ref id="B70">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zerovnik</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Stoka</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Mirtic</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Guncar</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Grdadolnik</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Staniforth</surname>
                            <given-names>R. A.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    . (<year>2011</year>).<article-title>Mechanisms of amyloid fibril formation&#x02014;focus on
                    domain-swapping</article-title>.<source>FEBS J</source>.<volume>278</volume>,<fpage>2263</fpage>
                    &#x02013;<lpage>2282</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08149.x</pub-id>
                    <?supplied-pmid 21535473?>
                    <pub-id pub-id-type="pmid">21535473</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
        <glossary>
            <def-list>
                <title>Abbreviations</title>
                <def-item>
                    <term>AD</term>
                    <def>
                        <p>Alzheimer's disease</p>
                    </def>
                </def-item>
                <def-item>
                    <term>APP</term>
                    <def>
                        <p>amyloid precursor protein</p>
                    </def>
                </def-item>
                <def-item>
                    <term>ADDLs</term>
                    <def>
                        <p>amyloid-derived diffusible ligands</p>
                    </def>
                </def-item>
                <def-item>
                    <term>TTR</term>
                    <def>
                        <p>transthyretin</p>
                    </def>
                </def-item>
                <def-item>
                    <term>SDS</term>
                    <def>
                        <p>sodium dodecyl sulphate.</p>
                    </def>
                </def-item>
            </def-list>
        </glossary>
    </back>
</article>